代谢工程在核黄素生产上的应用

核黄素(维生素B2)为天然水溶性的B族维生素,是维持机体代谢所必须的营养物质。目前核黄素的工业化生产主要有微生物发酵法和化学半合成法两种,其中微生物发酵法以生产工艺简单、原料廉价、环境友好以及资源可再生等优点而倍受世界核黄素生产商的青睐。代谢工程是近二十年来发展起来的新型学科,主要利用分子生物学技术对细胞进行遗传修饰,从而改进产物生成或细胞特性。为进一步提高核黄素产量,通过代谢工程手段构建出了核黄素高产菌株,其中尤以枯草芽孢杆菌最为成功。要得到较高的核黄素产率,必须保证碳架、能量等价物以及氧化还原辅(酶)因子在细胞代谢过程中处于适当的比率。以枯草芽孢杆菌进行核黄素生产为例,主要从增强碳源和能源利用效率、增强核黄素生物合成途径代谢流以及解除核黄素生物合成过程中的反馈调节方面综述了代谢工程在指导核黄素生产方面的应用,并讨论了其未来的发展方向。     

鲨烯合酶的研究进展

鲨烯合酶 (SqualeneSynthase,EC 2 5 1 2 1 ,简称SQS)是催化两分子的法呢酯焦磷酸 (Farnesyldiphos phate,简称FPP)缩合产生鲨烯 (SQ)的关键酶 ,而鲨烯是生物合成三萜、甾醇、胆固醇等萜烯类重要物质的共同前体[1 ,2 ] 。因此 ,对鲨烯合酶的研究倍受重视 ,迄今人们已对 1 4个不同物种中的鲨烯合酶进行了研究。本文简要综述国内外关于鲨烯合酶研究的进展。1　SQS在萜烯类化合物生物合成中的作用萜烯类化合物生物合成的途径见图 1 [1 ] ,SQS处于代谢途径中FPP到其它产物的分支点上 ,FPP除可以被鲨烯合酶催化产生鲨烯 (SQ)外 ,还…     

聚酮类化合物生物合成基因簇与药物筛选

由微生物和植物产生的聚酮类化合物的数量极其庞大,是一大类结构多样化和生物活性多样性的天然产物,已经成为新药的重要来源.介绍了3种类型聚酮类化合物生物合成基因簇的特点,即以模块形式存在的I型聚酮合酶,包含一套可重复使用结构域的Ⅱ型聚酮合酶以及不需要ACP参与,以植物中的查耳酮合酶为代表的Ⅲ型聚酮合酶.同时,还介绍了基于3种类型聚酮类化合物生物合成基因的特点,利用分子生物学方法构建筛选探针,进行当前药物基因筛选的进展.     

酵母线粒体ATP合酶生物合成及组装机制研究进展

线粒体ATP合酶是线粒体氧化磷酸化的关键酶,其功能缺陷会导致能量代谢障碍相关的线粒体疾病。线粒体ATP合酶是由多个亚基组成的蛋白复合物,其生物合成和组装是个复杂的生物过程。酵母是研究线粒体ATP合酶结构、生物合成和组装机制的模式实验材料之一,且相关研究取得了很多进展。本文概述了国内外用酿酒酵母研究线粒体ATP合酶的结构、调控线粒体ATP合酶亚基生物合成和组装的辅助蛋白及合酶的模块化组装过程的研究进展,以期为线粒体ATP合酶的工作机制及相关线粒体疾病的研究提供理论借鉴和参考依据。     

植物萜类生物合成中的后修饰酶

萜类化合物由于其结构类型丰富多样而被称为"terpenome".除了参与植物生长发育、环境应答等生理过程,萜类化合物还应用于医药、有机化工等领域.萜类的生物合成大致可分为前体形成、骨架构建以及后修饰三部分,基本骨架通常由萜类合酶催化形成,进一步在后修饰酶的作用下产生数以万计的萜类化合物.结合我们对香茶菜二萜生物合成的初步研究结果,本文主要针对近年来植物萜类生物合成中的一些有代表性的后修饰酶包括P450单氧酶、双键还原酶、酰基转移酶和糖基转移酶,进行研究现状分析与展望.     

白藜芦醇合酶的研究进展

白藜芦醇是一种重要的植物抗毒素,具有多种医疗保健作用,因此其应用前景 非常广泛,已引起多方关注。白藜芦醇合酶是白藜芦醇生物合成途径中的关键酶之一,它催化1分子4-香豆酰辅酶A和3分子丙二酰辅酶A反应合成白藜芦醇,它是白藜芦醇生物合成中惟一必需的酶,关于它的研究已广泛开展起来。本文综述了白藜芦醇的药理活性、白藜芦醇合 酶的酶学性质、诱导途径和机制以及分子生物学方面的研究进展。     

植物乙烯生物合成过程中活性氧的作用

大量的研究结果表明,活性氧参与植物乙烯生物合成过程具有明显的普遍性,超氧阴离子自由基是参与乙烯生物合成过程的主要活性氧。近年来研究的焦点主要从乙烯生物合成的关键调控酶ACC合酶及ACC氧化酶的酶活性、酶动力学特性、酶蛋白空间结构、酶基因表达水平等方面来阐明活性氧调控植物乙烯生物合成的机制。最新的研究表明：植物在各种正常或应激的生长条件下首先诱导了活性氧产生水平的变化,活性氧在基因或蛋白质水平上影响ACC合酶和ACC氧化酶的活性水平,从而调节乙烯的生物合成。本文首次综述了活性氧影响植物乙烯生物合成过程的最新研究进展,并对活性氧在植物乙烯生物合成中具有诱导与抑制并存的“双重性”作用进行了探讨。     

陆生植物鲨烯合酶适应性进化正选择位点分析

鲨烯合酶是三萜类皂苷生物合成途径中的关键酶,其活性的高低决定了三萜皂苷、植物甾醇等后续次生代谢物的含量．对鲨烯合酶进行正选择位点分析,可为识 别重要的功能位点提供有意义的信息．本研究在克隆获得五加科三七、葫芦科绞股蓝鲨烯合酶cDNA的基础上,结合GenBank中所登载的植物鲨烯合酶cDNA序列信息,利用位点模型检测并分析了38种陆生植物鲨烯合酶的适应性进化．结果显示,进化上相对保守的鲨烯合酶受到正选择作用,检测到的21个正选择位点大部分集中于第2跨膜区及其两侧,其中189S、194S、196S、265I、389P、390T、408A、410R和414N等9 个位点很可能与鲨烯合酶的活性有关．本研究从分子进化角度为调控三萜类化合物的生物合成提供了一个新的思路．     

白藜芦醇合酶的研究进展

白藜芦醇是一种重要的植物抗毒素,具有多种医疗保健作用,因此其应用前景非常广泛,已引起多方关注。白藜芦醇合酶是白藜芦醇生物合成途径中的关键酶之一,它催化1分子4—香豆酰辅酶A和3分子丙二酰辅酶A反应合成白藜芦醇,它是白藜芦醇生物合成中惟一必需的酶,关于它的研究已广泛开展起来。本文综述了白藜芦醇的药理活性、白藜芦醇合酶的酶学性质、诱导途径和机制以及分子生物学方面的研究进展。     

长松萝中一个聚酮合酶基因簇的克隆和鉴定

【目的】探索药用地衣长松萝(Usnea longissima Ach)聚酮化合物的生物合成基因簇,克隆聚酮合酶(PKS)基因并分析其功能。【方法】以长松萝地衣型真菌为材料,通过巢氏PCR获得聚酮合酶基因片段和原位杂交筛选基因组文库获得聚酮合酶基因及相邻基因簇。并对获得聚酮合酶进行分子系统进化分析和基因表达分析。【结果】获得药用地衣长松萝中的编码聚酮合酶基因UlPKS5的全长序列以及相邻修饰基因β-内酰胺酶和脱水酶。聚酮合酶UlPKS5含有酮体合成酶(KS),酰基转移酶(AT),产物模板(PT)以及酰基载体蛋白(ACP)结构域。分子系统进化分析显示UlPKS5属于非还原型聚酮合酶中第五组,与蒽醌类化合物生物合成相关。通过半定量RT-PCR分析表明山梨醇(10%)和蔗糖(2%和10%)能够强烈诱导UlPKS5基因表达。【结论】聚酮合酶(UlPKS5)及相邻修饰基因β-内酰胺酶和脱水酶与长松萝中蒽醌类化合物生物合成相关。     

Crystal structure of an archaeal pentameric riboflavin synthase in complex with a substrate analog inhibitor: stereochemical implications

Whereas eubacterial and eukaryotic riboflavin synthases form homotrimers, archaeal riboflavin synthases from Methanocaldococcus jannaschii and Methanothermobacter thermoautrophicus are homopentamers with sequence similarity to the 6,7-dimethyl-8-ribityllumazine synthase catalyzing the penultimate step in riboflavin biosynthesis. Recently it could be shown that the complex dismutation reaction catalyzed by the pentameric M. jannaschii riboflavin synthase generates riboflavin with the same regiochemistry as observed for trimeric riboflavin synthases. Here we present crystal structures of the pentameric riboflavin synthase from M. jannaschii and its complex with the substrate analog inhibitor, 6,7-dioxo-8-ribityllumazine. The complex structure shows five active sites located between adjacent monomers of the pentamer. Each active site can accommodate two substrate analog molecules in anti-parallel orientation. The topology of the two bound ligands at the active site is well in line with the known stereochemistry of a pentacyclic adduct of 6,7-dimethyl-8-ribityllumazine that has been shown to serve as a kinetically competent intermediate. The pentacyclic intermediates of trimeric and pentameric riboflavin synthases are diastereomers.     

Importance of malate synthase in the glyoxylate cycle of <Emphasis Type="Italic">Ashbya gossypii</Emphasis> for the efficient production of riboflavin

The glyoxylate cycle is an anabolic pathway that is necessary for growth on nonfermentable carbon sources such as vegetable oils and is important for riboflavin production by the filamentous fungus Ashbya gossypii. The aim of this study was to identify malate synthase in the glyoxylate cycle of A. gossypii and to investigate its importance in riboflavin production from rapeseed oil. The ACR268C gene was identified as the malate synthase gene that encoded functional malate synthase in the glyoxylate cycle. The ACR268C gene knockout mutant lost malate synthase activity, and its riboflavin production and oil consumption were 10- and 2-fold lower, respectively, than the values of the wild-type strain. In contrast, the ACR268C gene-overexpressing strain showed a 1.6-fold increase in the malate synthase activity and 1.7-fold higher riboflavin production than the control strain. These results demonstrate that the malate synthase in the glyoxylate cycle has an important role not only in riboflavin production but also in oil consumption.     

Biosynthesis of vitamin B2: diastereomeric reaction intermediates of archaeal and non-archaeal riboflavin synthases

The dismutation of 6,7-dimethyl-8-ribityllumazine catalyzed by riboflavin synthase affords riboflavin and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione. A pentacyclic adduct of two 6,7-dimethyl-8-ribityllumazines has been identified earlier as a catalytically competent reaction intermediate of the Escherichia coli enzyme. Acid quenching of reaction mixtures of riboflavin synthase of Methanococcus jannaschii, a paralog of 6,7-dimethyl-8-ribityllumazine synthase devoid of similarity with riboflavin synthases of eubacteria and eukaryotes, afforded a compound whose optical absorption and NMR spectra resemble that of the pentacyclic E. coli riboflavin synthase intermediate, whereas the circular dichroism spectra of the two compounds have similar envelopes but opposite signs. Each of the compounds could serve as a catalytically competent intermediate for the enzyme by which it was produced, but not vice versa. All available data indicate that the respective pentacyclic intermediates of the M. jannaschii and E. coli enzymes are diastereomers.     

Biosynthesis of riboflavin. 6,7-Dimethyl-8-ribityllumazine 5'-phosphate is not a substrate for riboflavin synthase.

Phosphotransferase from carrot is shown to catalyze the phosphorylation of 6,7-dimethyl-8-ribityllumazine specifically at position 5' of the ribityl side chain. The lumazine 5'-phosphate is neither a substrate nor an inhibitor of riboflavin synthase from Bacillus subtilis and Escherichia coli. It follows that the obligatory product of riboflavin synthase is riboflavin and not FMN.     

Evolution of vitamin B2 biosynthesis: riboflavin synthase of Arabidopsis thaliana and its inhibition by riboflavin

A synthetic gene specifying the catalytic domain of the Arabidopsis thaliana riboflavin synthase was expressed with high efficiency in a recombinant Escherichia coli strain. The recombinant pseudomature protein was shown to convert 6,7-dimethyl-8-ribityllumazine into riboflavin at a rate of 0.027 s-1 at 25 degrees C. The protein sediments at a rate of 3.9 S. Sedimentation equilibrium analysis afforded a molecular mass of 67.5 kDa, indicating a homotrimeric structure, analogous to the riboflavin synthases of Eubacteria and fungi. The protein binds its product riboflavin with relatively high affinity (Kd =1.1 microM). Product inhibition results in a characteristic sigmoidal velocity versus substrate concentration relationship. Characterization of the enzyme/product complex by circular dichroism and UV absorbance spectroscopy revealed a shift of the absorption maxima of riboflavin from 370 and 445 to 399 and 465 nm, respectively. Complete or partial sequences for riboflavin synthase orthologs were analyzed from 11 plant species. In each case for which the complete plant gene sequence was available, the catalytic domain was preceded by a sequence of 1-72 amino acid residues believed to function as plastid targeting signals. Comparison of all available riboflavin synthase sequences indicates that hypothetical gene duplication conducive to the two-domain architecture occurred very early in evolution.     

Biosynthesis of riboflavin 6,7-dimethyl-8-ribityllumazine 5′-phosphate is not a substrate for riboflavin synthase

Phosphotransferase from carrot is shown to catalyze the phosphorylation of 6,7-dimethyl-8-ribityllumazine specifically at position 5′ of the ribityl side chain. The lumazine 5′-phosphate is neither a substrate nor an inhibitor of riboflavin synthase from Bacillus subtilis and Escherichia coli. It follows that the obligatory product of riboflavin synthase is riboflavin and not FMN.     

Studies on the reaction mechanism of riboflavin synthase: X-ray crystal structure of a complex with 6-carboxyethyl-7-oxo-8-ribityllumazine

Riboflavin synthase catalyzes the disproportionation of 6,7-dimethyl-8-ribityllumazine affording riboflavin and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione. We have determined the structure of riboflavin synthase from Schizosaccharomyces pombe in complex with the substrate analog, 6-carboxyethyl-7-oxo-8-ribityllumazine at 2.1 A resolution. In contrast to the homotrimeric solution state of native riboflavin synthase, we found the enzyme to be monomeric in the crystal structure. Structural comparison of the riboflavin synthases of S. pombe and Escherichia coli suggests oligomer contact sites and delineates the catalytic site for dimerization of the substrate and subsequent fragmentation of the pentacyclic intermediate. The pentacyclic substrate dimer was modeled into the proposed active site, and its stereochemical features were determined. The model suggests that the substrate molecule at the C-terminal domain donates a four-carbon unit to the substrate molecule bound at the N-terminal domain of an adjacent subunit in the oligomer.     

Cloning of structural genes involved in riboflavin synthesis of the yeast Candida famata

The riboflavin overproducing mutants of the flavinogenic yeast Candida famata isolated by conventional selection methods are used for the industrial production of vitamin B2. Recently, a transformation system was developed for C. famata using the leu2 mutant as a recipient strain and Saccharomyces cerevislae LEU2 gene as a selective marker. In this paper the cloning of C. famata genes for riboflavin synthesis on the basis of developed transformation system for this yeast species is described. Riboflavin autotrophic mutants were isolated from a previously selected C. famata leu2 strain. C. famata genomic DNA library was constructed and used for cloning of the corresponding structural genes for riboflavin synthesis by complementation of the growth defects on a medium without leucine and riboflavin. As a result, the DNA fragments harboring genes RIB1, RIB2, RIB5, RIB6 and RIB7 encoding GTP cyclohydrolase, reductase, dimethylribityllumazine synthase, dihydroxybutanone phosphate synthase and riboflavin synthase, were isolated and subsequently subcloned to the smallest possible fragments. The plasmids with these genes successfully complemented riboflavin auxotrophies of the corresponding mutants of another flavinogenic yeast Pichia guilliermondii. This suggested that C. famata structural genes for riboflavin synthesis and not some of the supressor genes were cloned.     

A high-throughput screening platform for inhibitors of the riboflavin biosynthesis pathway

3,4-Dihydroxy-2-butanone 4-phosphate synthase, 6,7-dimethyl-8-ribityllumazine synthase, and riboflavin synthase of the riboflavin biosynthetic pathway are potential targets for novel antiinfective drugs. This article describes a platform for high-throughput screening for inhibitors of these enzymes. The assays can be monitored photometrically and have been shown to be robust, as indicated by Z factors 0.87. A (13)C NMR assay for hit verification of 3,4-dihydroxy-2-butanone 4-phosphate synthase inhibitors is also reported.